Tandem Diabetes Care, Inc.
TNDM
$21.01
$0.281.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 59.61% | 59.86% | -17,392.19% | 103.25% | 24.54% |
| Total Depreciation and Amortization | 2.89% | 1.30% | 1.55% | 0.81% | 2.51% |
| Total Amortization of Deferred Charges | -4.52% | -7.92% | 0.60% | 0.00% | 15.40% |
| Total Other Non-Cash Items | -5.40% | -74.48% | 297.00% | -5.49% | 2.39% |
| Change in Net Operating Assets | -131.15% | 257.66% | 75.07% | -254.17% | 278.13% |
| Cash from Operations | 187.03% | 48.05% | -270.55% | -59.98% | 607.66% |
| Capital Expenditure | 34.06% | -109.31% | 3.39% | 41.42% | 18.98% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -61.72% | 429.47% | 50.40% | 155.12% | -600.92% |
| Cash from Investing | -64.67% | 532.81% | 83.35% | 125.18% | -462.03% |
| Total Debt Issued | -- | -- | -- | -- | -100.00% |
| Total Debt Repaid | 100.00% | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -50.53% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 100.00% |
| Cash from Financing | 96.05% | -747.12% | -303.65% | 150.94% | -50.53% |
| Foreign Exchange rate Adjustments | -62.59% | 186.01% | -186.80% | 311.94% | -291.03% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 164.14% | 167.29% | -177.54% | 1,404.84% | 111.90% |